ArticleThe Lancet regional health. Europe2026

Fosfomycin versus ciprofloxacin for febrile neutropenia prophylaxis in high-risk haematological patients (FOVOCIP): a phase 3, open-label, multicentre, randomised, non-inferiority trial.

Ahinoa Fernández Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.